China Upgrades Biopharma To ‘Pillar’ Industry

More Stability To Policy Expectations?

 
• By Xu Hu
  
China upgrades biopharma industry status in latest national policy discussions. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia